Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ROP stock price vs DHR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DHR's multiple
Needs DHR P/E.
Implied fair value · at ROP's multiple
Needs ROP P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ROPER TECHNOLOGIES, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
DANAHER CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HONEYWELL INTERNATIONAL INC
ROP vs HON
EMERSON ELECTRIC CO
ROP vs EMR
Fortive Corp
ROP vs FTV
Keysight Technologies, Inc.
ROP vs KEYS
METTLER TOLEDO INTERNATIONAL INC/
ROP vs MTD
Vontier Corp
ROP vs VNT
AGILENT TECHNOLOGIES, INC.
ROP vs A
ILLUMINA, INC.
ROP vs ILMN
JOHNSON & JOHNSON
ROP vs JNJ
ABBOTT LABORATORIES
ROP vs ABT
LOEWS CORP
ROP vs L
BERKSHIRE HATHAWAY INC
ROP vs BRK-B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ROP can sustain its stronger margin profile and 12.3% revenue growth without leverage becoming a constraint, then the current price looks attractive versus DHR because ROP is valued at lower P/E and EV/EBITDA multiples despite better operating economics.
ROP trades at a meaningful discount to DHR-implied value range, with an implied price of $548.26 versus a current price of $391.97, suggesting 39.9% upside. The discount is supported by lower absolute multiples than DHR on P/E, P/S, and EV/EBITDA, even though ROP has stronger current profitability and growth.
Supporting Metrics
